Chapter/Section Purchase

1 Study Coverage
1.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Immune DTaP Vaccine
1.2.3 Therapy DTaP Vaccine
1.3 Market by Application
1.3.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Adult
1.3.3 Pediatric
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Region
2.4.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by Region (2023-2028)
2.5 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Region
2.5.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Region (2017-2022)
2.5.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Manufacturers
3.1.1 Global Top Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Manufacturers by Sales (2017-2022)
3.1.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine in 2021
3.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Manufacturers
3.2.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue in 2021
3.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Type
4.1.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Forecasted Sales by Type (2023-2028)
4.1.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Type (2017-2028)
4.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Type
4.2.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price by Type
4.3.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price by Type (2017-2022)
4.3.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Application
5.1.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Historical Sales by Application (2017-2022)
5.1.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Forecasted Sales by Application (2023-2028)
5.1.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Market Share by Application (2017-2028)
5.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Application
5.2.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Historical Revenue by Application (2017-2022)
5.2.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Application (2017-2028)
5.3 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price by Application
5.3.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price by Application (2017-2022)
5.3.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size by Type
6.1.1 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Type (2017-2028)
6.1.2 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Type (2017-2028)
6.2 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size by Application
6.2.1 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Application (2017-2028)
6.2.2 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Application (2017-2028)
6.3 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size by Country
6.3.1 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Country (2017-2028)
6.3.2 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size by Type
7.1.1 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Type (2017-2028)
7.1.2 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Type (2017-2028)
7.2 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size by Application
7.2.1 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Application (2017-2028)
7.2.2 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Application (2017-2028)
7.3 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size by Country
7.3.1 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Country (2017-2028)
7.3.2 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size by Type
8.1.1 Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size by Application
8.2.1 Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Application (2017-2028)
8.2.2 Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Application (2017-2028)
8.3 Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size by Region
8.3.1 Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size by Type
9.1.1 Latin America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Type (2017-2028)
9.1.2 Latin America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Type (2017-2028)
9.2 Latin America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size by Application
9.2.1 Latin America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Application (2017-2028)
9.2.2 Latin America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Application (2017-2028)
9.3 Latin America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size by Country
9.3.1 Latin America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Country (2017-2028)
9.3.2 Latin America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size by Type
10.1.1 Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size by Application
10.2.1 Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Application (2017-2028)
10.3 Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size by Country
10.3.1 Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Sanofi Pasteur
11.1.1 Sanofi Pasteur Corporation Information
11.1.2 Sanofi Pasteur Overview
11.1.3 Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Pasteur Recent Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Corporation Information
11.2.2 GlaxoSmithKline Overview
11.2.3 GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GlaxoSmithKline Recent Developments
11.3 Protein Sciences Corporation
11.3.1 Protein Sciences Corporation Corporation Information
11.3.2 Protein Sciences Corporation Overview
11.3.3 Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Protein Sciences Corporation Recent Developments
11.4 Novartis AG
11.4.1 Novartis AG Corporation Information
11.4.2 Novartis AG Overview
11.4.3 Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Novartis AG Recent Developments
11.5 Seqirus
11.5.1 Seqirus Corporation Information
11.5.2 Seqirus Overview
11.5.3 Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Seqirus Recent Developments
11.6 Merck Sharp & Dohme Corp
11.6.1 Merck Sharp & Dohme Corp Corporation Information
11.6.2 Merck Sharp & Dohme Corp Overview
11.6.3 Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Merck Sharp & Dohme Corp Recent Developments
11.7 Astellas Pharma US
11.7.1 Astellas Pharma US Corporation Information
11.7.2 Astellas Pharma US Overview
11.7.3 Astellas Pharma US Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Astellas Pharma US Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Astellas Pharma US Recent Developments
11.8 Pfizer Inc
11.8.1 Pfizer Inc Corporation Information
11.8.2 Pfizer Inc Overview
11.8.3 Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Pfizer Inc Recent Developments
11.9 Johnson & Johnson
11.9.1 Johnson & Johnson Corporation Information
11.9.2 Johnson & Johnson Overview
11.9.3 Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Johnson & Johnson Recent Developments
11.10 Lanzhou Institute of Biological Products Co., Ltd
11.10.1 Lanzhou Institute of Biological Products Co., Ltd Corporation Information
11.10.2 Lanzhou Institute of Biological Products Co., Ltd Overview
11.10.3 Lanzhou Institute of Biological Products Co., Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Lanzhou Institute of Biological Products Co., Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Lanzhou Institute of Biological Products Co., Ltd Recent Developments
11.11 AstraZeneca
11.11.1 AstraZeneca Corporation Information
11.11.2 AstraZeneca Overview
11.11.3 AstraZeneca Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 AstraZeneca Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 AstraZeneca Recent Developments
11.12 Emergent BioSolutions Inc
11.12.1 Emergent BioSolutions Inc Corporation Information
11.12.2 Emergent BioSolutions Inc Overview
11.12.3 Emergent BioSolutions Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Emergent BioSolutions Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Emergent BioSolutions Inc Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Industry Chain Analysis
12.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Mode & Process
12.4 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales and Marketing
12.4.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Channels
12.4.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Distributors
12.5 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Industry Trends
13.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Drivers
13.3 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Challenges
13.4 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Restraints
14 Key Findings in The Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer